Fund Overview of DSP Nifty Healthcare Etf-growth
-
₹12.6 CrAUM
-
₹146.09NAV
-
0.20%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of DSP Nifty Healthcare Etf-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 0.87% | NA | 6.12% |
| 6 Months | -2.42% | NA | 12.92% |
| 1 Year | 6.11% | 6.11% | 6.04% |
| 2 Years | 22.86% | 10.84% | 24.93% |
Asset Allocation
equities
99.91%other assets or cash equivalents
0.09%DSP Nifty Healthcare Etf-growth is one Equity mutual fund offered by DSP Mutual Fund. Launched on 01 Feb 2024, the fund aims Long-term capital growth. Investment in equity and equity related securities covered by Nifty Healthcare Index, subject to tracking error. It manages assets worth ₹12.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.2%. Fund Manager Manager Education Fund Manager Manager EducationAbout DSP Nifty Healthcare Etf-growth
The portfolio allocation consists of 99.91% in equities, 0.09% in other assets or cash equivalents.Managed by Diipesh Shah, it has delivered a return of 6.11% in the last year, a total return since inception of 12.05%.
While evaluating financial products many investors often compare best sip plan based on risk profile.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 3.26% | 3.70% | 5.26% | 25.72% | 17.01% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 3.26% | 3.70% | 5.26% | 25.72% | 17.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 4.09% | 0.41% | 7.00% | 27.58% | 16.93% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 4.09% | 0.41% | 7.00% | 27.58% | 16.93% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 2.06% | 3.89% | 9.47% | 25.16% | 15.93% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 2.06% | 3.89% | 9.47% | 25.16% | 15.93% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 4.00% | 0.18% | 6.10% | 26.51% | 15.90% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 4.00% | 0.18% | 6.10% | 26.51% | 15.90% |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | 3.17% | 3.44% | 4.19% | 24.41% | 15.77% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,064 | 3.17% | 3.44% | 4.19% | 24.41% | 15.77% |
More funds from DSP Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
DSP Healthcare Fund Regular-growth
|
₹2,892 | 4.24% | -1.05% | -2.98% | 2.45% | 21.25% |
|
DSP Healthcare Fund Direct-growth
|
₹2,892 | 4.36% | -0.72% | -2.34% | 3.82% | 22.88% |
|
DSP Healthcare Fund Regular-idcw
|
₹2,892 | 4.24% | -1.05% | -2.98% | 2.45% | 21.25% |
|
DSP Healthcare Fund Direct-idcw
|
₹2,892 | 4.36% | -0.72% | -2.34% | 3.82% | 22.88% |
|
DSP Nifty Healthcare Index Fund Direct-growth
|
₹16 | 0.37% | 0.84% | -2.46% | - | - |
|
DSP Nifty Healthcare Index Fund Regular-growth
|
₹16 | 0.33% | 0.70% | -2.76% | - | - |
|
DSP Nifty Healthcare Index Fund Direct-idcw
|
₹16 | 0.37% | 0.84% | -2.46% | - | - |
|
DSP Nifty Healthcare Index Fund Regular-idcw
|
₹16 | 0.33% | 0.70% | -2.76% | - | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹504.69 | 21.92% | 13.45% | 14.15% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹565.93 | 23.02% | 14.48% | 15.17% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹108.98 | 21.92% | 13.45% | 14.15% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹154.88 | 23.02% | 14.48% | 15.17% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹38.76 | 26.51% | 15.90% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹42.02 | 27.58% | 16.93% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹22.61 | 26.51% | 15.90% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹25.37 | 27.58% | 16.93% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹430.58 | 24.41% | 15.77% | 11.99% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹496.82 | 25.72% | 17.01% | 13.23% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 19.44% | ₹2.45 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.35% | ₹2.35 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 19.21% | ₹2.14 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.53% | ₹2.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.14% | ₹2.00 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.14% | ₹2.00 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.49% | ₹1.97 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 17.77% | ₹1.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 17.77% | ₹1.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.04% | ₹1.88 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.10% | ₹1.04 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.10% | ₹1.04 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 8.01% | ₹1.03 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.99% | ₹1.01 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.97% | ₹1.00 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.82% | ₹1.00 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.89% | ₹0.99 Cr |
| Max Healthcare Institute Ltd | Healthcare | 9.31% | ₹0.99 Cr |
| Cipla Ltd | Healthcare | 7.56% | ₹0.97 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.71% | ₹0.96 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.71% | ₹0.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.69% | ₹0.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.69% | ₹0.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.60% | ₹0.96 Cr |
| Cipla Ltd | Healthcare | 8.57% | ₹0.95 Cr |
| Cipla Ltd | Healthcare | 8.94% | ₹0.95 Cr |
| Cipla Ltd | Healthcare | 8.94% | ₹0.95 Cr |
| Cipla Ltd | Healthcare | 8.60% | ₹0.95 Cr |
| Cipla Ltd | Healthcare | 8.60% | ₹0.95 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.48% | ₹0.94 Cr |
| Cipla Ltd | Healthcare | 8.65% | ₹0.94 Cr |
| Cipla Ltd | Healthcare | 8.79% | ₹0.94 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.76% | ₹0.93 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.76% | ₹0.93 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.19% | ₹0.91 Cr |
| Cipla Ltd | Healthcare | 7.20% | ₹0.91 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.42% | ₹0.90 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.26% | ₹0.90 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.90% | ₹0.87 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.90% | ₹0.87 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.21% | ₹0.86 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.91% | ₹0.86 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.88% | ₹0.85 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.63% | ₹0.85 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.91% | ₹0.84 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.91% | ₹0.84 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.88% | ₹0.84 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.88% | ₹0.84 Cr |
| Cipla Ltd | Healthcare | 7.96% | ₹0.83 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.77% | ₹0.83 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.93% | ₹0.83 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.43% | ₹0.82 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.43% | ₹0.82 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.37% | ₹0.82 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.65% | ₹0.81 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.65% | ₹0.81 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.62% | ₹0.81 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.65% | ₹0.80 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.37% | ₹0.80 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.60% | ₹0.79 Cr |
| Lupin Ltd | Healthcare | 5.86% | ₹0.74 Cr |
| Lupin Ltd | Healthcare | 5.57% | ₹0.71 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.90% | ₹0.63 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.43% | ₹0.60 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.43% | ₹0.60 Cr |
| Lupin Ltd | Healthcare | 5.57% | ₹0.58 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.61% | ₹0.58 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.50% | ₹0.58 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.34% | ₹0.57 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.34% | ₹0.57 Cr |
| Lupin Ltd | Healthcare | 5.20% | ₹0.56 Cr |
| Lupin Ltd | Healthcare | 5.01% | ₹0.56 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.33% | ₹0.54 Cr |
| Lupin Ltd | Healthcare | 4.84% | ₹0.53 Cr |
| Lupin Ltd | Healthcare | 4.84% | ₹0.53 Cr |
| Laurus Labs Ltd | Healthcare | 4.17% | ₹0.53 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.77% | ₹0.53 Cr |
| Lupin Ltd | Healthcare | 4.89% | ₹0.52 Cr |
| Lupin Ltd | Healthcare | 4.89% | ₹0.52 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.69% | ₹0.51 Cr |
| Laurus Labs Ltd | Healthcare | 4.03% | ₹0.51 Cr |
| Lupin Ltd | Healthcare | 4.69% | ₹0.50 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.74% | ₹0.50 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.81% | ₹0.48 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.49% | ₹0.48 Cr |
| Laurus Labs Ltd | Healthcare | 4.38% | ₹0.47 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.43% | ₹0.46 Cr |
| Laurus Labs Ltd | Healthcare | 3.99% | ₹0.44 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.10% | ₹0.44 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.41% | ₹0.44 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.87% | ₹0.43 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.98% | ₹0.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.98% | ₹0.42 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.35% | ₹0.42 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.28% | ₹0.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.93% | ₹0.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.79% | ₹0.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.79% | ₹0.42 Cr |
| Laurus Labs Ltd | Healthcare | 4.00% | ₹0.42 Cr |
| Laurus Labs Ltd | Healthcare | 3.77% | ₹0.42 Cr |
| Laurus Labs Ltd | Healthcare | 3.77% | ₹0.42 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.22% | ₹0.41 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.24% | ₹0.41 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.42% | ₹0.38 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.61% | ₹0.38 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.55% | ₹0.37 Cr |
| Laurus Labs Ltd | Healthcare | 3.46% | ₹0.37 Cr |
| Laurus Labs Ltd | Healthcare | 3.46% | ₹0.37 Cr |
| Laurus Labs Ltd | Healthcare | 3.44% | ₹0.37 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.37% | ₹0.36 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.24% | ₹0.36 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.24% | ₹0.36 Cr |
| Biocon Ltd | Healthcare | 2.78% | ₹0.36 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.28% | ₹0.36 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.18% | ₹0.35 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.16% | ₹0.35 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.16% | ₹0.35 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.23% | ₹0.34 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.23% | ₹0.34 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.23% | ₹0.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.20% | ₹0.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹0.34 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹0.34 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.24% | ₹0.34 Cr |
| Biocon Ltd | Healthcare | 2.69% | ₹0.34 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.12% | ₹0.34 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.11% | ₹0.33 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.11% | ₹0.33 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.54% | ₹0.33 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.92% | ₹0.32 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.90% | ₹0.32 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.90% | ₹0.32 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.31 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.31 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.31 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.74% | ₹0.30 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.74% | ₹0.30 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.37% | ₹0.30 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.30% | ₹0.30 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.32% | ₹0.29 Cr |
| Biocon Ltd | Healthcare | 2.80% | ₹0.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.72% | ₹0.29 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.28% | ₹0.29 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.53% | ₹0.28 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.59% | ₹0.28 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.59% | ₹0.28 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.48% | ₹0.27 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.48% | ₹0.27 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.53% | ₹0.27 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.12% | ₹0.27 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.57% | ₹0.27 Cr |
| Biocon Ltd | Healthcare | 2.38% | ₹0.26 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.34% | ₹0.26 Cr |
| Biocon Ltd | Healthcare | 2.41% | ₹0.26 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.43% | ₹0.26 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.33% | ₹0.25 Cr |
| Biocon Ltd | Healthcare | 2.36% | ₹0.25 Cr |
| Biocon Ltd | Healthcare | 2.28% | ₹0.25 Cr |
| Biocon Ltd | Healthcare | 2.28% | ₹0.25 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.37% | ₹0.25 Cr |
| Biocon Ltd | Healthcare | 2.17% | ₹0.23 Cr |
| Biocon Ltd | Healthcare | 2.17% | ₹0.23 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.18% | ₹0.23 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.01% | ₹0.22 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.06% | ₹0.22 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.01% | ₹0.22 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.21 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.21 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.80% | ₹0.20 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.80% | ₹0.20 Cr |
| Abbott India Ltd | Healthcare | 1.81% | ₹0.19 Cr |
| Abbott India Ltd | Healthcare | 1.39% | ₹0.18 Cr |
| Abbott India Ltd | Healthcare | 1.40% | ₹0.18 Cr |
| Abbott India Ltd | Healthcare | 1.57% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.62% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.62% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.55% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.55% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.55% | ₹0.17 Cr |
| Abbott India Ltd | Healthcare | 1.53% | ₹0.16 Cr |
| Syngene International Ltd | Healthcare | 1.36% | ₹0.14 Cr |
| Piramal Pharma Ltd | Healthcare | 1.26% | ₹0.14 Cr |
| Piramal Pharma Ltd | Healthcare | 1.26% | ₹0.14 Cr |
| Syngene International Ltd | Healthcare | 1.26% | ₹0.14 Cr |
| Syngene International Ltd | Healthcare | 1.26% | ₹0.14 Cr |
| Syngene International Ltd | Healthcare | 1.22% | ₹0.14 Cr |
| Syngene International Ltd | Healthcare | 1.26% | ₹0.14 Cr |
| Syngene International Ltd | Healthcare | 1.25% | ₹0.13 Cr |
| Piramal Pharma Ltd | Healthcare | 1.25% | ₹0.13 Cr |
| Syngene International Ltd | Healthcare | 1.25% | ₹0.13 Cr |
| Piramal Pharma Ltd | Healthcare | 1.25% | ₹0.13 Cr |
| Piramal Pharma Ltd | Healthcare | 1.15% | ₹0.13 Cr |
| Piramal Pharma Ltd | Healthcare | 0.96% | ₹0.12 Cr |
| Piramal Pharma Ltd | Healthcare | 1.08% | ₹0.12 Cr |
| Piramal Pharma Ltd | Healthcare | 0.88% | ₹0.11 Cr |
| Piramal Pharma Ltd | Healthcare | 1.02% | ₹0.11 Cr |
| Syngene International Ltd | Healthcare | 0.80% | ₹0.10 Cr |
| Syngene International Ltd | Healthcare | 0.96% | ₹0.10 Cr |
| Syngene International Ltd | Healthcare | 0.77% | ₹0.10 Cr |
| Granules India Ltd | Healthcare | 0.69% | ₹0.07 Cr |
| Reverse Repo | Unspecified | 0.21% | ₹0.03 Cr |
| Net Receivables | Unspecified | 0.24% | ₹0.02 Cr |
| Reverse Repo | Unspecified | 0.20% | ₹0.02 Cr |
| Net Receivables | Unspecified | 0.08% | ₹0.01 Cr |
| Reverse Repo | Unspecified | 0.09% | ₹0.01 Cr |
| Reverse Repo | Unspecified | 0.09% | ₹0.01 Cr |
| Reverse Repo | Unspecified | 0.04% | ₹0.01 Cr |
| Reverse Repo | Unspecified | 0.04% | ₹0.00 Cr |
| Reverse Repo | Unspecified | 0.04% | ₹0.00 Cr |
| Net Receivables | Unspecified | 0.07% | ₹0.00 Cr |
| Reverse Repo | Unspecified | 0.04% | ₹0.00 Cr |
| Net Receivables | Unspecified | 0.02% | ₹0.00 Cr |
| Reverse Repo | Unspecified | 0.02% | ₹0.00 Cr |
| Net Receivables | Unspecified | 0.02% | ₹0.00 Cr |
| Net Receivables | Unspecified | 0.02% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.01% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.01% | ₹0.00 Cr |
| Reverse Repo | Unspecified | 0.00% | ₹0.00 Cr |
| Net Payables | Unspecified | -0.11% | ₹-0.01 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.02 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹496.82 | 25.72% | 17.01% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹345.18 | 25.72% | 17.01% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹42.02 | 27.58% | 16.93% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹25.37 | 27.58% | 16.93% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹44.02 | 25.16% | 15.93% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹26.51 | 25.16% | 15.93% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹38.76 | 26.51% | 15.90% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹22.61 | 26.51% | 15.90% | - |
| SBI Healthcare Opportunities Fund-growth |
₹430.58 | 24.41% | 15.77% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹271.24 | 24.41% | 15.77% | - |
Frequently Asked Questions
DSP Nifty Healthcare Etf-growth
What is the current AUM of DSP Nifty Healthcare Etf-growth?
As of Tue Mar 31, 2026, DSP Nifty Healthcare Etf-growth manages assets worth ₹12.6 crore
How has DSP Nifty Healthcare Etf-growth performed recently?
- 3 Months: 0.87%
- 6 Months: -2.42%
What is the long-term performance of DSP Nifty Healthcare Etf-growth?
- Since Inception: 12.05%
What is the portfolio composition of DSP Nifty Healthcare Etf-growth?
Equity: 99.91%, Others: 0.09%.
Who manages DSP Nifty Healthcare Etf-growth?
DSP Nifty Healthcare Etf-growth is managed by Diipesh Shah from DSP Mutual Fund.
What is the market-cap allocation of DSP Nifty Healthcare Etf-growth?
Large Cap: 62.64%, Mid Cap: 35.71%, Small Cap: 1.65%.
Which are the top companies DSP Nifty Healthcare Etf-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 19.44% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 18.35% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 19.21% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 18.53% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 18.14% of the fund's portfolio
Which are the major sectors DSP Nifty Healthcare Etf-growth focuses on?
- Healthcare – 999.03% of the fund's portfolio
- Unspecified – 0.97% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





